Gelteq Limited’s Lock-Up Period Set To Expire on April 28th (NASDAQ:GELS)

Gelteq’s (NASDAQ:GELS) lock-up period will expire on Monday, April 28th. Gelteq had issued 1,300,000 shares in its public offering on October 29th. The total size of the offering was $5,200,000 based on an initial share price of $4.00. After the end of the company’s lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Gelteq Trading Up 5.9 %

Shares of Gelteq stock opened at $0.93 on Monday. Gelteq has a 52-week low of $0.77 and a 52-week high of $5.50. The firm has a 50-day moving average price of $1.30.

Institutional Trading of Gelteq

A hedge fund recently bought a new stake in Gelteq stock. Citadel Advisors LLC acquired a new stake in Gelteq Limited (NASDAQ:GELS) in the fourth quarter, according to its most recent filing with the SEC. The fund acquired 23,748 shares of the company’s stock, valued at approximately $55,000. Citadel Advisors LLC owned approximately 0.25% of Gelteq at the end of the most recent quarter.

Gelteq Company Profile

Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition.